Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hochhauser

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Oncotarget|December 10, 2015
NF-Y activates genes of metabolic pathways altered in cancer cellsPaolo Benatti, Maria Luisa Chiaramonte, Mariangela Lorenzo, et al.
Journal of the National Cancer Institute|January 1, 2016
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal CancerValeria Santoro, Ruochen Jia, Hannah Thompson, et al.
International Journal of Oncology|July 13, 2005
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agentsSoo Lo, Berend Tolner, Jan-Willem Taanman, et al.
Nuclear Medicine Communications|April 9, 2008
The role of 99mTc-depreotide in the management of neuroendocrine tumoursTahir Shah, Ilona Kulakiene, Ann-Marie Quigley, et al.
Molecular Cancer Therapeutics|February 28, 2013
A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoterDaniel Hochhauser, Rob Glynne-Jones, Vanessa Potter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000)Jenny Wu, Peter H Clingen, Victoria J Spanswick, et al.
Medicine|March 4, 2016
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor MarginPulathis N Siriwardana, Tu Vinh Luong, Jennifer Watkins, et al.
Cancers|June 13, 2025
Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre StudyUmair Mahmood, Joanna Lynch, Simran Kaur Sandhu, et al.
Bioorganic & Medicinal Chemistry|July 10, 2010
Targeting the ICB2 site of the topoisomerase IIalpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamideAndrew Franks, Christopher Tronrud, Konstantinos Kiakos, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cellsN Minh Le, Alan M Sielaff, Amanda J Cooper, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Oncotarget|December 10, 2015
NF-Y activates genes of metabolic pathways altered in cancer cellsPaolo Benatti, Maria Luisa Chiaramonte, Mariangela Lorenzo, et al.
Journal of the National Cancer Institute|January 1, 2016
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal CancerValeria Santoro, Ruochen Jia, Hannah Thompson, et al.
International Journal of Oncology|July 13, 2005
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agentsSoo Lo, Berend Tolner, Jan-Willem Taanman, et al.
Nuclear Medicine Communications|April 9, 2008
The role of 99mTc-depreotide in the management of neuroendocrine tumoursTahir Shah, Ilona Kulakiene, Ann-Marie Quigley, et al.
Molecular Cancer Therapeutics|February 28, 2013
A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoterDaniel Hochhauser, Rob Glynne-Jones, Vanessa Potter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000)Jenny Wu, Peter H Clingen, Victoria J Spanswick, et al.
Medicine|March 4, 2016
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor MarginPulathis N Siriwardana, Tu Vinh Luong, Jennifer Watkins, et al.
Cancers|June 13, 2025
Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre StudyUmair Mahmood, Joanna Lynch, Simran Kaur Sandhu, et al.
Bioorganic & Medicinal Chemistry|July 10, 2010
Targeting the ICB2 site of the topoisomerase IIalpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamideAndrew Franks, Christopher Tronrud, Konstantinos Kiakos, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cellsN Minh Le, Alan M Sielaff, Amanda J Cooper, et al.
Pageof 7